Prospecting the Neurosciences Job Market

Almost a year after the "Decade of the Brain," neuroscience remains one of the fastest growing disciplines in all biology, researchwise and jobwise. The health of this job market relates to the overall expansion that continues in the neurosciences, says Richard Nakamura, acting deputy director at the National Institute of Mental Health. He notes that some especially promising areas include human genomes and genomics, and particularly, understanding the behavioral consequences and epidemiology of

Written byKaren Young Kreeger
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Almost a year after the "Decade of the Brain," neuroscience remains one of the fastest growing disciplines in all biology, researchwise and jobwise. The health of this job market relates to the overall expansion that continues in the neurosciences, says Richard Nakamura, acting deputy director at the National Institute of Mental Health. He notes that some especially promising areas include human genomes and genomics, and particularly, understanding the behavioral consequences and epidemiology of mental illness.

"For mental health, we are going after diseases with a high inherited component such as schizophrenia or autism," Nakamura reports. "These are all not Mendelian inherited, so finding out how genes interact to produce these diseases is a really critical issue and will require a lot of resources." Other disease targets include depression; bipolar diseases, such as manic depression; Alzheimer's disease, Parkinson's disease and other dementia disorders; anxiety disorders; and loss of cognition disorders.

Some ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies